Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.

Santomasso BD, Park JH, Salloum D, Riviere I, Flynn J, Mead E, Halton E, Wang X, Senechal B, Purdon T, Cross JR, Liu H, Vachha B, Chen X, DeAngelis LM, Li D, Bernal Y, Gonen M, Wendel HG, Sadelain M, Brentjens RJ.

Cancer Discov. 2018 Aug;8(8):958-971. doi: 10.1158/2159-8290.CD-17-1319. Epub 2018 Jun 7.

PMID:
29880584
2.

Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.

Tang J, Salloum D, Carney B, Brand C, Kossatz S, Sadique A, Lewis JS, Weber WA, Wendel HG, Reiner T.

Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7441-E7449. doi: 10.1073/pnas.1705013114. Epub 2017 Aug 21.

3.

A balance of outward and linear inward ionic currents is required for generation of slow-wave oscillations.

Golowasch J, Bose A, Guan Y, Salloum D, Roeser A, Nadim F.

J Neurophysiol. 2017 Aug 1;118(2):1092-1104. doi: 10.1152/jn.00240.2017. Epub 2017 May 24.

4.

Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid.

Menon D, Salloum D, Bernfeld E, Gorodetsky E, Akselrod A, Frias MA, Sudderth J, Chen PH, DeBerardinis R, Foster DA.

J Biol Chem. 2017 Apr 14;292(15):6303-6311. doi: 10.1074/jbc.M116.772988. Epub 2017 Feb 21.

5.

A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells.

Patel D, Salloum D, Saqcena M, Chatterjee A, Mroz V, Ohh M, Foster DA.

J Biol Chem. 2017 Jan 20;292(3):936-944. doi: 10.1074/jbc.M116.757864. Epub 2016 Dec 12.

6.

Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Boice M, Salloum D, Mourcin F, Sanghvi V, Amin R, Oricchio E, Jiang M, Mottok A, Denis-Lagache N, Ciriello G, Tam W, Teruya-Feldstein J, de Stanchina E, Chan WC, Malek SN, Ennishi D, Brentjens RJ, Gascoyne RD, Cogné M, Tarte K, Wendel HG.

Cell. 2016 Oct 6;167(2):405-418.e13. doi: 10.1016/j.cell.2016.08.032. Epub 2016 Sep 29.

7.

A disorder-enhanced quasi-one-dimensional superconductor.

Petrović AP, Ansermet D, Chernyshov D, Hoesch M, Salloum D, Gougeon P, Potel M, Boeri L, Panagopoulos C.

Nat Commun. 2016 Jul 22;7:12262. doi: 10.1038/ncomms12262.

8.

Reentrant Phase Coherence in Superconducting Nanowire Composites.

Ansermet D, Petrović AP, He S, Chernyshov D, Hoesch M, Salloum D, Gougeon P, Potel M, Boeri L, Andersen OK, Panagopoulos C.

ACS Nano. 2016 Jan 26;10(1):515-23. doi: 10.1021/acsnano.5b05450. Epub 2016 Jan 8.

PMID:
26727335
9.

Crystal structure of Sc1.91In1.39Mo15Se19, containing Mo6 and Mo9 clusters.

Gougeon P, Gall P, Salloum D.

Acta Crystallogr E Crystallogr Commun. 2015 Jun 10;71(Pt 7):760-2. doi: 10.1107/S2056989015010634. eCollection 2015 Jul 1.

10.

Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

Foster DA, Salloum D, Menon D, Frias MA.

J Biol Chem. 2014 Aug 15;289(33):22583-8. doi: 10.1074/jbc.R114.566091. Epub 2014 Jul 2. Review.

11.

Na4.25Mo15S19: a novel ternary reduced molybdenum sulfide containing Mo6 and Mo9 clusters.

Salloum D, Gougeon P, Gall P.

Acta Crystallogr Sect E Struct Rep Online. 2014 May 31;70(Pt 6):i30. doi: 10.1107/S160053681401201X. eCollection 2014 Jun 1.

12.

Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Salloum D, Mukhopadhyay S, Tung K, Polonetskaya A, Foster DA.

Mol Cancer Ther. 2014 Mar;13(3):733-41. doi: 10.1158/1535-7163.MCT-13-0762. Epub 2014 Jan 16.

13.

Na3.88Mo15Se19: a novel ternary reduced molybdenum selenide containing Mo6 and Mo9 clusters.

Salloum D, Gougeon P, Gall P.

Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 25;69(Pt 10):i67-i68. doi: 10.1107/S1600536813025907. eCollection 2013.

14.

Na2.9KMo12S14: a novel quaternary reduced molybdenum sulfide containing Mo12 clusters with a channel structure.

Gougeon P, Gall P, Salloum D.

Acta Crystallogr Sect E Struct Rep Online. 2013 May 25;69(Pt 6):i38. doi: 10.1107/S1600536813013603. Print 2013 Jun 1.

15.

High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.

Yellen P, Saqcena M, Salloum D, Feng J, Preda A, Xu L, Rodrik-Outmezguine V, Foster DA.

Cell Cycle. 2011 Nov 15;10(22):3948-56. doi: 10.4161/cc.10.22.18124. Epub 2011 Nov 15.

16.

Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).

Xu L, Salloum D, Medlin PS, Saqcena M, Yellen P, Perrella B, Foster DA.

J Biol Chem. 2011 Jul 22;286(29):25477-86. doi: 10.1074/jbc.M111.249631. Epub 2011 May 28.

17.

Multiband superconductivity in the Chevrel phases SnMo6S8 and PbMo6S8.

Petrović AP, Lortz R, Santi G, Berthod C, Dubois C, Decroux M, Demuer A, Antunes AB, Paré A, Salloum D, Gougeon P, Potel M, Fischer O.

Phys Rev Lett. 2011 Jan 7;106(1):017003. Epub 2011 Jan 6.

PMID:
21231768
18.

Real-space vortex glass imaging and the vortex phase diagram of SnMo6S8.

Petrović AP, Fasano Y, Lortz R, Senatore C, Demuer A, Antunes AB, Paré A, Salloum D, Gougeon P, Potel M, Fischer Ø.

Phys Rev Lett. 2009 Dec 18;103(25):257001. Epub 2009 Dec 15.

PMID:
20366275
19.

V(1.42)in(1.83)mo(15)se(19).

Gougeon P, Gall P, Salloum D, Potel M.

Acta Crystallogr Sect E Struct Rep Online. 2010 Sep 18;66(Pt 10):i73. doi: 10.1107/S1600536810036834.

20.

Cr1.45Tl1.87Mo15Se19, a monoclinic variant of the hexagonal In3Mo15Se19 type.

Gougeon P, Salloum D, Potel M.

Acta Crystallogr C. 2009 Dec;65(Pt 12):i87-90. doi: 10.1107/S0108270109047301. Epub 2009 Nov 25.

PMID:
19966422
21.

Synthesis, electronic and crystal structures, and physical studies of the superconductor Cs(~1)Mo12S14, final step of the condensation of the Mo6L8(i)L6(a) unit.

Gougeon P, Salloum D, Cuny J, Le Pollès L, Le Floch M, Gautier R, Potel M.

Inorg Chem. 2009 Sep 7;48(17):8337-41. doi: 10.1021/ic900960g.

PMID:
19645498
22.

The Chevrel phase HgMo(6)S(8).

Salloum D, Gougeon P, Potel M.

Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 18;65(Pt 5):i34. doi: 10.1107/S1600536809012495.

23.

Mo(15)S(20): first evidence of a new molybdenum cluster type in a metastable solid-state compound.

Salloum D, Gautier R, Potel M, Gougeon P.

Chemistry. 2006 Nov 15;12(33):8513-7.

PMID:
17009370
24.

Fibronectin and cell attachment to cell and protein resistant polyelectrolyte surfaces.

Olenych SG, Moussallem MD, Salloum DS, Schlenoff JB, Keller TC.

Biomacromolecules. 2005 Nov-Dec;6(6):3252-8.

PMID:
16283753
25.

Ba(4)Mo(12)S(18): A superconductor containing the dimeric unit (Mo(6))(2)S(24), the missing link between the Mo(6)S(14) and Mo(9)S(17) units.

Salloum D, Gautier R, Potel M, Gougeon P.

Angew Chem Int Ed Engl. 2005 Feb 18;44(9):1363-5. No abstract available.

PMID:
15662676
26.

Vascular smooth muscle cells on polyelectrolyte multilayers: hydrophobicity-directed adhesion and growth.

Salloum DS, Olenych SG, Keller TC, Schlenoff JB.

Biomacromolecules. 2005 Jan-Feb;6(1):161-7.

PMID:
15638516
27.

Cs2Mo15S19: a novel ternary reduced molybdenum sulfide containing Mo6 and Mo9 clusters.

Picard S, Salloum D, Gougeon P, Potel M.

Acta Crystallogr C. 2004 Jun;60(Pt 6):i61-2. Epub 2004 May 11.

PMID:
15178831
28.

Protein adsorption modalities on polyelectrolyte multilayers.

Salloum DS, Schlenoff JB.

Biomacromolecules. 2004 May-Jun;5(3):1089-96.

PMID:
15132703
30.

Cs(6)Mo(27)S(31): a novel ternary reduced molybdenum sulfide containing Mo(9) and Mo(18) clusters.

Picard S, Salloum D, Gougeon P, Potel M.

Acta Crystallogr C. 2003 Nov;59(Pt 11):i112-4. Epub 2003 Oct 22.

PMID:
14605378
31.

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein.

Lee SF, Halperin SA, Salloum DF, MacMillan A, Morris A.

Infect Immun. 2003 Apr;71(4):2272-5.

Supplemental Content

Loading ...
Support Center